---
title: 'Low tumor interleukin-1β expression predicts a limited effect of adjuvant
  platinum-based chemotherapy for patients with completely resected lung adenocarcinoma:
  An identification and validation study'
date: '2024-04-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38614857/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240414191153&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: This study identified and validated low tumor IL-1β expression
  as a potential biomarker of a limited response to adjuvant platinum-based chemotherapy
  after complete resection of pulmonary adenocarcinoma. This finding has the potential
  to inform adjuvant treatment ...'
disable_comments: true
---
CONCLUSIONS: This study identified and validated low tumor IL-1β expression as a potential biomarker of a limited response to adjuvant platinum-based chemotherapy after complete resection of pulmonary adenocarcinoma. This finding has the potential to inform adjuvant treatment ...